INTERVIEW: Bausch & Lomb eyes market listing as acquisition offers roll in

The 160-year-old eye drug, surgery and consumer product specialist Bausch & Lomb checked a box on the to-do list for its return to the public markets with a stop at the 31st Annual JP Morgan Healthcare Conference in San Francisco, during a period when the company also is getting offers from Big Pharma suitors.